Formulary Monographs [GLICLAZIDE, 682020]

GLICLAZIDE
SULPHONYLUREAS
Treatment of diabetes mellitus. May be of benefit in retinopathy.
Gastro intestinal upset, nausea, hypoglycemia, weight gain, dizziness. c.f. prescribing in liver and renal disease p. 14; 30.
Intial dose: 40- 80 mg daily with breakfast, gradually increasing to
320 mg daily . Doses of more than 160 mg daily are given in 2 divided doses. M odified-release: initial dose is 30 mg once daily , increasing if necessary in step s of